Media Summary: A policy expert explains how the arrival of more Michael Zeglinski, Vice President of Specialty Lori Reilly, PhRMA's Executive VP for Policy, Research, and Membership, at Intelligence Squared U.S. Full debate: ...

Will Biosimilars Cure High Drug Prices - Detailed Analysis & Overview

A policy expert explains how the arrival of more Michael Zeglinski, Vice President of Specialty Lori Reilly, PhRMA's Executive VP for Policy, Research, and Membership, at Intelligence Squared U.S. Full debate: ... Experts remark on the challenges faced by payers with the A bipartisan pair of lawmakers is pursuing a first-in-the-nation approach to This landmark law introduces sweeping reforms to

Photo Gallery

Will Biosimilars Cure High Drug Prices?
Biosimilar Breakdown: Can Lower Drug Prices Survive the PBM Squeeze?
The Next Drugs:  An Atlantic Policy Update on Biosimilars
Biosimilars: Costs and Insurance Coverage
Pricing of Biosimilars With Biologics and Other Biosimilars
Skyrocketing Brand Drug Prices
Review of the Proposed Generic Drug & Biosimilars User Fees & Further Examination of Drug Shortages
Will Biosimilars Impact the Cost of Specialty Drugs?
High Cost of Prescription Drugs | Sam Roxborough | TEDxPascoCountySchools
Biosimilars: Costs and Insurance Coverage
The Changing Drug Landscape - Biologics: the high cost of breakthrough medicine
PhRMA's Lori Reilly: High Drug Prices Pay for New Cures
View Detailed Profile
Will Biosimilars Cure High Drug Prices?

Will Biosimilars Cure High Drug Prices?

Many medical experts predict that

Biosimilar Breakdown: Can Lower Drug Prices Survive the PBM Squeeze?

Biosimilar Breakdown: Can Lower Drug Prices Survive the PBM Squeeze?

Featured Guest: Stan Mehr — Editor of

The Next Drugs:  An Atlantic Policy Update on Biosimilars

The Next Drugs: An Atlantic Policy Update on Biosimilars

ATLPoliticsPolicy

Biosimilars: Costs and Insurance Coverage

Biosimilars: Costs and Insurance Coverage

A policy expert explains how the arrival of more

Pricing of Biosimilars With Biologics and Other Biosimilars

Pricing of Biosimilars With Biologics and Other Biosimilars

Perspective on the potential effects of

Skyrocketing Brand Drug Prices

Skyrocketing Brand Drug Prices

The average annual

Review of the Proposed Generic Drug & Biosimilars User Fees & Further Examination of Drug Shortages

Review of the Proposed Generic Drug & Biosimilars User Fees & Further Examination of Drug Shortages

The Subcommittee on Health

Will Biosimilars Impact the Cost of Specialty Drugs?

Will Biosimilars Impact the Cost of Specialty Drugs?

Michael Zeglinski, Vice President of Specialty

High Cost of Prescription Drugs | Sam Roxborough | TEDxPascoCountySchools

High Cost of Prescription Drugs | Sam Roxborough | TEDxPascoCountySchools

Sam Roxborough discusses the

Biosimilars: Costs and Insurance Coverage

Biosimilars: Costs and Insurance Coverage

Are

The Changing Drug Landscape - Biologics: the high cost of breakthrough medicine

The Changing Drug Landscape - Biologics: the high cost of breakthrough medicine

http://www.empire.ca/ They

PhRMA's Lori Reilly: High Drug Prices Pay for New Cures

PhRMA's Lori Reilly: High Drug Prices Pay for New Cures

Lori Reilly, PhRMA's Executive VP for Policy, Research, and Membership, at Intelligence Squared U.S. Full debate: ...

Biosimilars: An Alternative to Expensive Biologic Medicines

Biosimilars: An Alternative to Expensive Biologic Medicines

Biologics

Highlights: The Future of Biosimilar Drugs in the U.S.

Highlights: The Future of Biosimilar Drugs in the U.S.

The first

Will increased biosimilar use benefit the U.S. health care system?

Will increased biosimilar use benefit the U.S. health care system?

Biosimilars

Challenges for Payers With Costs of Biosimilars

Challenges for Payers With Costs of Biosimilars

Experts remark on the challenges faced by payers with the

Session Update: Reducing the Costs of Prescription Drugs

Session Update: Reducing the Costs of Prescription Drugs

A bipartisan pair of lawmakers is pursuing a first-in-the-nation approach to

Improving Drug Affordability, The Promise of Biosimilars

Improving Drug Affordability, The Promise of Biosimilars

Biosimilars

Biosimilar Medications — What Patients Need to Know

Biosimilar Medications — What Patients Need to Know

What are

FAQ: What is the Inflation Reduction Act & How Does It Impact Affordability of Biologic Therapies?

FAQ: What is the Inflation Reduction Act & How Does It Impact Affordability of Biologic Therapies?

This landmark law introduces sweeping reforms to